Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

809
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
809
Impact of Groups on Groups01:19

Impact of Groups on Groups

245
Social psychologists analyze how groups influence one another, shaping social structures and interactions through both cooperation and competition. These dynamics manifest in various ways, ranging from economic partnerships to intergroup conflicts that shape societal structures and perceptions.Cooperation and Competition in Intergroup RelationsIntergroup relationships vary across contexts, sometimes fostering cooperation and mutual benefit while at other times leading to conflict and...
245
Impact01:30

Impact

490
Impact occurs when two bodies collide, leading to the application of impulsive forces between them. Analyzing impact mechanics involves considering two colliding particles moving along a line known as the line of impact, which passes through their centers and is perpendicular to the contact plane.
When particles with different initial velocities collide, they induce deformation by applying equal and opposite impulses. At the point of maximum deformation, the particles move together with...
490
Impact of Groups on Individuals01:28

Impact of Groups on Individuals

345
Groups play a fundamental role in shaping individual behavior, as they establish norms that guide interactions and decision-making. Social psychology examines how individuals conform to group expectations, often adjusting their attitudes and actions to align with group norms. These norms can be formal, such as workplace policies, or informal, such as unspoken social expectations within a fraternity.Conformity and Social InfluenceConformity arises when individuals modify their behaviors or...
345
Impact of Individuals on a Group01:25

Impact of Individuals on a Group

317
In social psychology, the interplay between individuals and groups is a central concern, particularly regarding how individual actions and characteristics influence group processes and outcomes. While much research emphasizes the group's power in shaping individual behavior, it is equally significant to understand how individuals contribute to the functioning, development, and success of groups.Individual Roles in Group Productivity and Decision-MakingIndividuals are not passive participants in...
317

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Chronic obstructive pulmonary disease. A chronic inflammatory disease].

Revue medicale de Liege·2022
Same author

[Fixed combination of budesonide, formoterol, glycopyrronium for the treatment of severe COPD : Trixeo Aerosphere®].

Revue medicale de Liege·2022
Same author

[Feasibility and effectiveness study of a simplified mobile self-education and self-monitoring application for patients with severe chronic obstructive pulmonary disease].

Revue medicale de Liege·2022
Same author

White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer.

Lung·2021
Same author

[Managing of dyspnea in oncology].

Revue medicale de Liege·2021
Same author

[Pre-cancerous lung lesions and lung cancer screening].

Revue medicale de Liege·2021
Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026
Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026
Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026
Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026
Same journal

[Climate change and skin].

Revue medicale de Liege·2026
Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026
See all related articles

Related Experiment Video

Updated: Jan 30, 2026

In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data
06:14

In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data

Published on: April 18, 2019

6.9K

[IMPACT study in COPD].

J L Corhay1

  • 1Service de Pneumologie CHU Sart Tilman, Liège, Belgique.

Revue Medicale De Liege
|January 26, 2019
PubMed
Summary
This summary is machine-generated.

Triple therapy combining long-acting beta-agonists, muscarinic antagonists, and inhaled corticosteroids significantly reduces exacerbations in COPD patients. This approach also improves respiratory function and quality of life compared to dual therapies.

Keywords:
BronchodilatorsChronic obstructive pulmonary diseaseExacerbationsInhaled corticosteroidsTriple therapyAerosol

More Related Videos

Fast Imaging Technique to Study Drop Impact Dynamics of Non-Newtonian Fluids
10:09

Fast Imaging Technique to Study Drop Impact Dynamics of Non-Newtonian Fluids

Published on: March 5, 2014

12.9K
Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.7K

Related Experiment Videos

Last Updated: Jan 30, 2026

In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data
06:14

In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data

Published on: April 18, 2019

6.9K
Fast Imaging Technique to Study Drop Impact Dynamics of Non-Newtonian Fluids
10:09

Fast Imaging Technique to Study Drop Impact Dynamics of Non-Newtonian Fluids

Published on: March 5, 2014

12.9K
Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.7K

Area of Science:

  • Pulmonology
  • Pharmacology
  • Clinical Trials

Background:

  • The efficacy of triple therapy (long-acting beta-agonist [LABA], long-acting muscarinic antagonist [LAMA], inhaled corticosteroid [ICS]) for preventing chronic obstructive pulmonary disease (COPD) exacerbations requires further clarification.
  • Comparison with dual therapies (LABA-ICS or LABA-LAMA) is essential to establish optimal treatment strategies.

Purpose of the Study:

  • To compare the effectiveness of triple therapy (LABA-LAMA-ICS) versus dual therapies (LABA-ICS, LABA-LAMA) in reducing COPD exacerbation rates.
  • To evaluate the impact of triple therapy on pulmonary function, quality of life, dyspnea, and mortality.

Main Methods:

  • Phase 3, double-blind, randomized controlled trial (IMPACT study).
  • Investigated a single inhaler triple therapy (vilanterol/umeclidinium/fluticasone furoate) against dual therapy combinations.
  • Primary outcome was the reduction in the rate of moderate to severe exacerbations.

Main Results:

  • Triple therapy demonstrated significant improvements in reducing moderate to severe exacerbations compared to dual therapies.
  • Enhanced respiratory function, improved quality of life, and reduced dyspnea were observed with triple therapy.
  • The treatment was generally well-tolerated, with no significant differences in mortality noted.

Conclusions:

  • Triple therapy (LABA-LAMA-ICS) offers superior benefits over dual therapies for symptomatic COPD patients experiencing exacerbations.
  • Provides an evidence base supporting current GOLD guidelines for triple therapy in managing COPD.
  • Supports the use of triple therapy as a valuable treatment option for improving patient outcomes in COPD.